Abstract
Nicorandil, a K+ channel opener is frequently used in ischaemic heart disease (IHD). Diabetes mellitus is often associated with IHD. There is a possibility of alteration of blood glucose level (BGL) by nicorandil when used with sulfonylureas by influencing insulin release as it’s a K+ channel opener. The study has been done to know the changes of BGL after administration of low-dose nicorandil with sulfonylureas in Diabetic as well as normal rabbits. The study has been done on normal and alloxan induced diabetic rabbits by keeping them 12 hrs fasting & water ad lib. Glibenclamide was given in a dose of 50µg/kg body weight &Nicorandil was administered in a dose of 10,20,40,80 and160µg/kg body weight concurrently. The drugs were given by oral route. Normal saline treated rabbits were used as control. Blood samples were collected from marginal ear vein & BGL was estimated in the process described by Hultmann. The statistical significance was calculated by employing student “t” test. Glibenclamide per se in a dose of 50 µg/kg produced significant hypoglycemia, Nicorandil in in doses of 20µg/kg abolishes the hypoglycemic effect of glibenclamide, & in dose of 40µg/kg produced significant hyperglycemia. Nicorandil, a K+ channel opener can increase blood glucose level by its action probably on ATP sensitive K+ channel of β cells of pancreas only at a certain dose range (20 to40 µg/kg body weight doses) for 2 to 3 hours., but no change in BGL in 80 and 160 µg/kg body weight doses which are also relatively low doses than conventional dose. The sensitivity of low dose nicorandil is more than sulfonylureas on β cells of pancreas & the response is dose dependent. In alloxan induced diabetic rabbit, the change in BGL is not so marked probably due to lack of β cells of pancreas.
Keywords: Blood Glucose, Nicorandil, Sulphonylureas.
References
- Davis SN, Granner DK. Insulin. Oral hypoglycemic agents & the pharmacology of the endocrine pancreas.In ,HardmanJG , Limbird LE ,Gilman AG (eds) Goodman & Gilman´s . The Parmacological Basis of Therapeutics, 10th ed. New York, McGraw-Hill, 2001, 1679 -1714
- Bertrm G, KatzungSusn B, Anthony J Trevor. Basic and Clinical Pharmacology 11th ed. New Delhi,Tata McGraw Hill Education Pvt Ltd, 2010, 191-205
- Frank Riemann, Frances M Ashcroft, Fiona M .Gribble. Structural basis for the interference Between Nicorandil and Sulfonylure Action.American Diabetes Association. 2010, 90, 291-366
- Rorsman P. The pancreatic beta-cell as a fuel sensor, an electrophysiologist’s viewpoint. Diabetologia. 2005, 40, 487– 495
- Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly-rectifying potassium channels in smooth muscle. Physiol Rev 1997, 77, 1165–1232
- Nichols CG, Ledere r WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 1991, 261, H1675–H1686
- Edwards G Weston AH. Pharmacology of the potassium channel openers. Cardiovascular Drugs and Therapy 1995, 9, 185-193
- Rang HP, Dale MM, Ritter JM, Flower RJ. Rang and Dale´s Pharmacology.6th ed ; Churchill Livingstone Elsevier. 2007, 298-320
- Krolewski AS, Warram JH. Epidemiology of late complications of diabetiesIn , Khan CR, Weir GC (eds) Joslin´s Diabetes Mellitus, 13th ed. Philadelphia, Williams & Wilkins, 2000, 605-619
- Hultman E. Rapid specific method for determination of aldosaccharides in body fluids. Nature, 1959, 183, 108
- Cogolludo AL, Perez-Vizcaino F, Fajardo S, Ibarra M, Tamargo J. Effects of nicorandil as compared to mixtures of sodium nitroprusside and levcromakalim in isolated rat aorta. Br J Pharmacol 1999, 126, 1025–1033
- Mensah GA. Mokdad AH, Ford E. Obesity, metabolic syndrome and type 2 diabetes, emerging epidemics and their cardiovascular implications. CardiolClin. 2004, 22, 485-504
- Ashcroft FM, Gribble FM. ATP sensitive K + channels & insulin secretion, their role in health and diseases. Diabetologia, 1999, 42. 903-19
- Valensi P, Slama G. Sulphonylureas and cardiovascular risk, facts and controversies. The British Journal of Diabetes and Vascular diseases, 2006, 159-165
- Aguilar-Bryan L, Bryan J. Molecular biology of ATP-sensitive potassium channels. Endocr Rev 1999, 2,101–135
- Ashcroft FM, Gribble FM. ATP-sensitive K + channels in health and disease. Diabetologia 1999, 42,903–919
- Ahmed SM. Study of the effect of Nicorandil on Insulin production and its influence on hypoglycemic action of glibenclamide on Alloxan induced diabetic rats. MD Thesis, JSS Medical College Mysore; 2006, 6-7
- Boes U, Wallner S, Wascher TC. Acute effects of nicorandil on glucose tolerance in subjects with borderline fasting blood glucose levels. WieKlinWochenschr, 2001, 113(3-4), 127-9
- Morrow DA, Gersh BJ. Chronic coronary Artery disease.Braunwald´s Heart disease, A Text book of Cardiovascular Medicine, 2008, 8th edition, Samders , Philadelphia, 1393 – 1417
- SasakiJ, Saeki Y, Kawasaki, Umeno M, Ikeda K, Handa K, Arakawa K. A multicenter comparison of ncorandil and diltiazam on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease. Cardiovas Drugs Ther 1992, 6(5), 471-4
Corresponding Author
Dr Anupam Nath Gupta
Associate Professor, Department of Pharmacology, North Bengal Medical College, Darjeeling, West Bengal
DOI: https://dx.doi.org/10.18535/jmscr/v9i1.47
